The Influence of Cataract on Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO).


Journal

Translational vision science & technology
ISSN: 2164-2591
Titre abrégé: Transl Vis Sci Technol
Pays: United States
ID NLM: 101595919

Informations de publication

Date de publication:
01 04 2021
Historique:
entrez: 18 5 2021
pubmed: 19 5 2021
medline: 29 6 2021
Statut: ppublish

Résumé

To investigate the influence of lens opacifications on fluorescence lifetime imaging ophthalmoscopy (FLIO). Forty-seven eyes of 45 patients were included. Mean fluorescence lifetimes (Tm) were recorded with a fluorescence lifetime imaging ophthalmoscope in a short spectral channel (SSC) and a long spectral channel (LSC). Retinal and lens autofluorescence lifetimes were measured in subjects before and after cataract surgery. Lens opacification was graded using the Lens Opacities Classification System III (LOCS III) classification. The retinal Tm decreased significantly after cataract surgery in both spectral channels (SSC: -53%, P < 0.0001; LSC: -26%, P = 0.0041). The lens Tm differed significantly between the crystalline and the artificial lens in both spectral channels (P < 0.0001). The "nuclear opacity" and "nuclear color" score of the LOCS III classification correlated significantly with the mean Tm difference in both spectral channels (P < 0.0001). Lens opacification results in significantly longer retinal Tm. Therefore the lens status has to be considered when performing cross-sectional fluorescence lifetime analysis. Cataract-formation and cataract-surgery needs to be considered when conducting longitudinal studies. Grading of nuclear opacity following the LOCS III classification provides an approximate conversion formula for the mean change of lifetimes, which can be helpful in the interpretation of data in patients with lens opacities. FLIO is significantly influenced by lens opacities. Using a lens opacity grading scheme and measuring fluorescence lifetimes before and after cataract surgery, an approximative conversion formula can be calculated, which enables the comparison of lifetimes after cataract surgery or over the course of time.

Identifiants

pubmed: 34004011
pii: 2772542
doi: 10.1167/tvst.10.4.33
pmc: PMC8088233
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

33

Références

PLoS One. 2015 Jul 20;10(7):e0131640
pubmed: 26192624
PLoS One. 2018 Dec 28;13(12):e0209194
pubmed: 30592718
Microsc Res Tech. 2007 May;70(5):410-9
pubmed: 17393496
Int Ophthalmol. 2001;23(4-6):399-404
pubmed: 11944867
Biomed Tech (Berl). 2005 Sep;50(9):263-7
pubmed: 16185033
Retina. 2020 Oct;40(10):1929-1937
pubmed: 31860523
Invest Ophthalmol Vis Sci. 2019 May 1;60(6):2165-2172
pubmed: 31108547
Biomed Opt Express. 2016 Aug 01;7(9):3198-3210
pubmed: 27699092
Transl Vis Sci Technol. 2019 May 8;8(3):15
pubmed: 31114715
J Biomed Opt. 2015 Jun;20(6):61106
pubmed: 25769278
Eye (Lond). 2019 Aug;33(8):1271-1279
pubmed: 30923356
Transl Vis Sci Technol. 2020 Jul 09;9(8):13
pubmed: 32855860
Ophthalmologica. 2020;243(3):195-206
pubmed: 31743906
Invest Ophthalmol Vis Sci. 2012 Jun 26;53(7):4076-84
pubmed: 22491402
Invest Ophthalmol Vis Sci. 2016 Mar;57(3):832-41
pubmed: 26934141
Exp Eye Res. 2013 Nov;116:190-8
pubmed: 24007642
Arch Ophthalmol. 1993 Jun;111(6):831-6
pubmed: 8512486
J Biomed Opt. 2004 Nov-Dec;9(6):1214-22
pubmed: 15568942
Invest Ophthalmol Vis Sci. 2017 Jul 1;58(9):3616-3627
pubmed: 28728169
Invest Ophthalmol Vis Sci. 2014 Apr 03;55(4):2106-13
pubmed: 24569585
Invest Ophthalmol Vis Sci. 2015 May;56(5):3329-36
pubmed: 26024116
Ophthalmology. 1991 May;98(5 Suppl):741-56
pubmed: 2062510
Retina. 2019 May;39(5):879-888
pubmed: 30985551

Auteurs

Joel-Benjamin Lincke (JB)

Department of Ophthalmology, Inselspital, Bern University Hospital, Bern, Switzerland.

Chantal Dysli (C)

Department of Ophthalmology, Inselspital, Bern University Hospital, Bern, Switzerland.

Damian Jaggi (D)

Department of Ophthalmology, Inselspital, Bern University Hospital, Bern, Switzerland.

Rahel Fink (R)

Department of Ophthalmology, Inselspital, Bern University Hospital, Bern, Switzerland.

Sebastian Wolf (S)

Department of Ophthalmology, Inselspital, Bern University Hospital, Bern, Switzerland.

Martin S Zinkernagel (MS)

Department of Ophthalmology, Inselspital, Bern University Hospital, Bern, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH